CXCL10 and neoplasm: In addition to deactivating local T cells, (D)-2-HG also diminishes the chemotaxis of immune cells to the tumor sites by inhibiting the secretion of C-X-C motif chemokine ligand 10 (CXCL10) by dendritic cells (16).